↓ Skip to main content

Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities

Overview of attention for article published in Frontiers in oncology, April 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities
Published in
Frontiers in oncology, April 2022
DOI 10.3389/fonc.2022.839765
Pubmed ID
Authors

Yun Chen, Zhengfei Zhu, Weixin Zhao, Qi Liu, Junhua Zhang, Jiaying Deng, Dashan Ai, Saiquan Lu, Liuqing Jiang, Ihsuan Tseng, Huixun Jia, Kuaile Zhao

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 11%
Student > Bachelor 1 11%
Student > Postgraduate 1 11%
Student > Doctoral Student 1 11%
Unknown 5 56%
Readers by discipline Count As %
Unspecified 1 11%
Nursing and Health Professions 1 11%
Medicine and Dentistry 1 11%
Unknown 6 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2022.
All research outputs
#22,853,823
of 25,481,734 outputs
Outputs from Frontiers in oncology
#16,050
of 22,575 outputs
Outputs of similar age
#380,770
of 448,401 outputs
Outputs of similar age from Frontiers in oncology
#964
of 1,536 outputs
Altmetric has tracked 25,481,734 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,575 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,401 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,536 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.